These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 3071519
1. [Involvement of cAMP dependent protein kinase in the reversion of a NIH/3T3 cell line transformed by a ras oncogene (EJ-NIH/3T3)]. Oda A. Hokkaido Igaku Zasshi; 1988 Sep; 63(5):747-53. PubMed ID: 3071519 [Abstract] [Full Text] [Related]
3. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells]. Fujita H. Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920 [Abstract] [Full Text] [Related]
5. Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts. Sugimoto Y, Ikawa Y, Nakauchi H. Cancer Res; 1991 Jan 01; 51(1):99-104. PubMed ID: 1670996 [Abstract] [Full Text] [Related]
10. Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines. Wehner JM, Malkinson AM, Wiser MF, Sheppard JR. J Cell Physiol; 1981 Aug 01; 108(2):175-84. PubMed ID: 6267082 [Abstract] [Full Text] [Related]
11. Cyclic AMP can partially restore platelet-derived growth factor-stimulated prostaglandin E2 biosynthesis, and calcium mobilization in EJ-ras-transformed NIH-3T3 cells. Olinger PL, Benjamin CW, Gorman RR, Connor JA. J Cell Physiol; 1989 May 01; 139(2):335-45. PubMed ID: 2541140 [Abstract] [Full Text] [Related]
12. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity. Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP. Exp Cell Res; 1993 Apr 01; 205(2):232-9. PubMed ID: 8482334 [Abstract] [Full Text] [Related]
13. SCH 51344 inhibits ras transformation by a novel mechanism. Kumar CC, Prorock-Rogers C, Kelly J, Dong Z, Lin JJ, Armstrong L, Kung HF, Weber MJ, Afonso A. Cancer Res; 1995 Nov 01; 55(21):5106-17. PubMed ID: 7585559 [Abstract] [Full Text] [Related]
14. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function. Kuo ML, Chou YW, Chau YP, Huang TS. Mol Carcinog; 1997 Apr 01; 18(4):221-31. PubMed ID: 9142217 [Abstract] [Full Text] [Related]
15. The effect of n-6 fatty acids on normal and v-Ki ras transformed NIH-3T3 cells. Cantrill RC, Ells GW, de Antueno RJ, Elliot M, Raha SK, Horrobin DF. Anticancer Res; 1992 Apr 01; 12(6B):2197-201. PubMed ID: 1338278 [Abstract] [Full Text] [Related]
16. Identification of genes that exhibit increased expression after flat reversion of NIH/3T3 cells transformed by human activated Ha-ras oncogene. Müllauer L, Suzuki H, Fujita H, Katabami M, Kuzumaki N. Cancer Lett; 1991 Jul 26; 59(1):37-43. PubMed ID: 1878859 [Abstract] [Full Text] [Related]
17. Reduced induction of c-fos but not of c-myc expressions in a nontumorigenic revertant R1 of Ej-ras-transformed NIH/3T3 cells treated with 12-O-tetradecanoylphorbol-13-acetate (TPA). Suzuki H, Fujita H, Ogiso Y, Oda A, Kuzumaki N, Uchino J. Exp Cell Res; 1989 Oct 26; 184(2):524-8. PubMed ID: 2509225 [Abstract] [Full Text] [Related]
18. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Shantz LM, Pegg AE. Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886 [Abstract] [Full Text] [Related]
19. Cell-free system studies on the phosphorylation of the 17,000-20,000 dalton protein induced by phorbol ester in human leukemic cells and evidence for a similar event in virally transformed murine fibroblasts. Feuerstein N, Nishikawa M, Cooper HL. Cancer Res; 1985 Jul 01; 45(7):3243-51. PubMed ID: 3159476 [Abstract] [Full Text] [Related]
20. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival. Xin H, Geng Y, Pramanik R, Choubey D. J Cell Biochem; 2003 Jan 01; 88(1):191-204. PubMed ID: 12461788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]